Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-08-13 2019-06-12
Drug Identification Number 00436208 00436208
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name Lidocaine Hydrochloride Injection USP Lidocaine Hydrochloride Injection USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 5mL ANSYR 10 x 5mL ANSYR
ATC code C01BB C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-11 2019-06-11
Estimated end date Unknown 2019-10-18
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Current inventory is on preventative allocation
Health Canada comments